Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats

Journal of Neuroscience

Volumn 22, Issue 15, 2002, Pages 6773-6780

  Schmidt, Brian L ^a,b   Tambeli, Claudia H ^a,b,c   Barletta, Justine ^a,b   Luo, Lei ^a,b   Green, Paul ^a,b   Levine, Jon D ^a,b   Gear, Robert W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Analgesia; Antinociception; Capsaicin; Dopamine release; Jaw opening reflex; Microdialysis; Morphine; Noxious stimulation; Nucleus accumbens; Pain; Tolerance; opioid receptors; opioid receptors

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CAPSAICIN; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPENTIXOL; MECAMYLAMINE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG CROSS TOLERANCE; DRUG TOLERANCE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 0036703986     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-15-06773.2002     Document Type: Article

References (52)

1. Ableitner A, Schulz R (1992) Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: Involvement of mu opioid receptors. J Pharmacol Exp Ther 262:415-423.
2. Ahn DK, Kim YS, Park JS (1998) Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett 243:105-108.
3. Altier N, Stewart J (1998) Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther 285:208-215.
4. Altier N, Stewart J (1999) The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65:2269-2287.
5. Badiani A, Leone P, Stewart J (1995) Intra-VTA injections of the muopioid antagonist CTOP enhance locomotor activity. Brain Res 690:112-116.
6. Banks D, Kuriakose M, Matthews B (1992) Modulation by peripheral conditioning stimuli of the responses of trigeminal brain stem neurones and of the jaw opening reflex to tooth pulp stimulation in chronically prepared, anaesthetized cats. Exp Physiol 77:343-349.
7. Belforte JE, Barcelo AC, Pazo JH (2001) Striatal modulation of the jaw opening reflex. Brain Res 891:138-147.
8. Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML (1995) General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res 700:205-212.
9. Borg PJ, Taylor DA (1997) Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 355:582-588.
10. Borgland SL (2001) Acute opioid receptor desensitization and tolerance: Is there a link? Clin Exp Pharmacol Physiol 28:147-154.
11. Buelke-Sam J, Holson JF, Bazare JJ, Young JF (1978) Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci 28:157-162.
12. Caine SB, Heinrichs SC, Coffin VL, Koob GF (1995) Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692:47-56.
13. Chiang CY, Dostrovsky JO, Sessle BJ (1990) Role of anterior pretectal nucleus in somatosensory cortical descending modulation of jaw-opening reflex in rats. Brain Res 515:219-226.
14. Chiang CY, Dostrovsky JO, Sessle BJ (1991) Periaqueductal gray matter and nucleus raphe magnus involvement in anterior pretectal nucleus-induced inhibition of jaw-opening reflex in rats. Brain Res 544:71-78.
15. Christie MJ, Trisdikoon P, Chesher GB (1982) Tolerance and cross tolerance with morphine resulting from physiological release of endogenous opiates. Life Sci 31:839-845.
16. Churchill L, Kalivas PW (1992) Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: Lack of a role for receptor upregulation. Synapse 11:47-57.
17. Devine DP, Leone P, Wise RA (1993) Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur J Pharmacol 243:55-64.
18. Dill RE, Costa E (1977) Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus. Neuropharmacology 16:323-326.
19. Gear RW, Levine JD (1995) Antinociception produced by an ascending spino-supraspinal pathway. J Neurosci 15:3154-3161.
20. Gear RW, Aley KO, Levine JD (1999) Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 19:7175-7181.
21. Girardot MN, Holloway FA (1984) Intermittent cold water stress-analgesia in rats: Cross-tolerance to morphine. Pharmacol Biochem Behav 20:631-633.
22. Gold LH, Stinus L, Inturrisi CE, Koob GF (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253:45-51.
23. Harrison LM, Kastin AJ, Zadina JE (1998) Opiate tolerance and dependence: Receptors, G-proteins, and antiopiates. Peptides 19:1603-1630.
24. Heyman JS, Jiang Q, Rothman RB, Mosberg HI, Porreca F (1989) Modulation of mu-mediated antinociception by delta agonists: Characterization with antagonists. Eur J Pharmacol 169:43-52.
25. Horan P, Taylor J, Yamamura HI, Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260:1237-1243.
26. Kalivas PW, Bronson M (1985) Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin. Neuropharmacology 24:931-936.
27. Kalivas PW, Churchill L, Klitenick MA (1993) The circuitry mediating the translation of motivational stimuli into adaptive motor responses. In: Limbic Motor Circuits and Neuropsychiatry (Kalivas PW, Barnes CD, eds), pp 237-287. Boca Raton, FL: CRC.
28. Kelley AE, Bless EP, Swanson CJ (1996) Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J Pharmacol Exp Ther 278:1499-1507.
29. Lewis JW, Sherman JE, Liebeskind JC (1981) Opioid and non-opioid stress analgesia: Assessment of tolerance and cross-tolerance with morphine. J Neurosci 1:358-363.
30. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN (1998) mu opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54:321-326.
31. Maisonneuve IM, Warner LM, Glick SD (2001) Biphasic dose-related effects of morphine on dopamine release. Drug Alcohol Depend 65:55-63.
32. Mason P, Strassman A, Maciewicz R (1985) Is the jaw-opening reflex a valid model of pain? Brain Res 357:137-146.
33. Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubié M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL (1998) Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor. J Neurosci 18:7285-7295.
34. Moses J, Loucks JA, Watson HL, Matuszewich L, Hull EM (1995) Dopaminergic drugs in the medial preoptic area and nucleus accumbens: Effects on motor activity, sexual motivation, and sexual performance. Pharmacol Biochem Behav 51:681-686.
35. Negri L, Improta G, Lattanzi R, Potenza RL, Luchetti F, Melchiorri P (1995) Interaction between the mu-agonist dermorphin and the deltaagonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-oploid receptor binding. Br J Pharmacol 116:2931-2938.
36. Okamura H, Murakami T, Yokoyama C, Nakamura T, Ibata Y (1997) Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists. J Pharmacol Exp Ther 280:1031-1037.
37. Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates. New York: Academic.
38. Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL (1987) Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. J Pharmacol Exp Ther 241:393-400.
39. Pothos E, Rada P, Mark GP, Hoebel BG (1991) Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566:348-350.
40. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234.
41. Schmidt BL, Tambeli C, Gear RW, Levine JD (2001) Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. Neuroscience 126:129-136.
42. Schmidt BL, Tambeli CH, Levine JD, Gear RW (2002) μ/δ cooperativity and opposing κ-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur J Neurosci 15:861-868.
43. Spanagel R, Almeida OF, Shippenberg TS (1994) Evidence that norbinaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur J Pharmacol 264:157-162.
44. Stinus L, Winnock M, Kelley AE (1985) Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates. Psychopharmacology (Berl) 85:323-328.
45. Stinus L, Cador M, Le Moal M (1992) Interaction between endogenous opioids and dopamine within the nucleus accumbens. Ann NY Acad Sci 654:254-273.
46. Takeda M, Tanimoto T, Ojima K, Matsumoto S (1998) Suppressive effect of vagal afferents on the activity of the trigeminal spinal neurons related to the jaw-opening reflex in rats: Involvement of the endogenous opioid system. Brain Res Bull 47:49-56.
47. Wettstein JG, Grouhel A (1996) Opioid antagonist profile of SC norbinaltorphimine in the formalin paw assay. Pharmacol Biochem Behav 53:411-416.
48. Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
49. Yoburn BC, Chen J, Huang T, Inturrisi CE (1985) Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J Pharmacol Exp Ther 235:282-286.
50. Yu LC, Han JS (1990) The neural pathway from nucleus accumbens to amygdala in morphine analgesia of the rabbit. Sheng Li Xue Bao 42:277-283.
51. Zhang S, Tang JS, Yuan B, Jia H (1998) Inhibitory effects of electrical stimulation of ventrolateral orbital cortex on the rat jaw-opening reflex. Brain Res 813:359-366.
52. Zhang S, Tang JS, Yuan B, Jia H (1999) Electrically evoked inhibitory effects of the nucleus submedius on the jaw-opening reflex are mediated by ventrolateral orbital cortex and periaqueductal gray matter in the rat. Neuroscience 92:867-875.